# Pulmocide

**Canonical:** https://apis.io/providers/pulmocide/  
**Website:** https://pulmocide.com/  
**APIs profiled:** 0

Pulmocide Ltd. is a privately held, clinical-stage biopharmaceutical company headquartered at 44 Southampton Buildings in London, United Kingdom, with a US entity (Pulmocide Inc.) in Boston, Massachusetts. It develops novel inhaled medicines for pulmonary aspergillosis and other difficult-to-treat respiratory diseases, delivering drug directly to the site of infection in the lung to achieve high local exposure with low systemic exposure. Its lead asset is opelconazole (formerly PC945), an inhaled triazole antifungal active against Aspergillus that has received US FDA Orphan Drug, Fast Track and Qualified Infectious Disease Product designations; the company reported Phase 2 OPERA-S safety results in 2024 and announced termination of the Phase 3 OPERA-T study in 2025. Pulmocide is a drug developer, not a software or platform company: it publishes no developer program, no public API, no SDKs and no machine-readable API contract of any kind. This profile therefore records identity, corporate web properties and probed absence rather than API artifacts.

## Kin Score — 6.9 / 100 (minimal)

Scored 2026-09-02 under rubric 0.18.0. Trend: flat (+0.0 from 6.9).

| Facet | Score |
|---|---|
| Discoverability | 57.4 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 0.0 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Pulmocide Domain Security** — TLSv1.3

## Tags

Company, Biotechnology, Pharmaceuticals, Life Sciences, Clinical Trials, Respiratory, Antifungal, Drug Development, Healthcare, United Kingdom

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/pulmocide/). Scores are computed from the provider's own public artifacts under a published rubric.